Antimicrobial peptides and inflammatory bowel disease

Antimicrobial Peptides and Innate Immunity

Volumn , Issue , 2013, Pages 255-273

  Jager, Simon ^a,b   Stange, Eduard F ^a,b   Wehkamp, Jan ^a,b  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84979789349     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-0348-0541-4_10     Document Type: Chapter

References (101)

1. Akin H, Tahan G, Ture F et al (2011) Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease. J Crohns Colitis 5:14-18
2. Aldhous MC, Noble CL, Satsangi J (2009) Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease. PLoS One 4:e6285
3. Anderson CA, Boucher G, Lees CW et al (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43:246-252
4. Ayabe T, Wulff H, Darmoul D et al (2002) Modulation of mouse Paneth cell alpha-defensin secretion by mIKCa1, a Ca2+-activated, intermediate conductance potassium channel. J Biol Chem 277:3793-3800
5. Bager P, Arnved J, Ronborg S et al (2010) Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial. J Allergy Clin Immunol 125:123-130
6. Barrett JC, Hansoul S, Nicolae DL et al (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40:955-962
7. Bentley RW, Pearson J, Gearry RB et al (2010) Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol 105(2):354-359
8. Cadwell K, Liu JY, Brown SL et al (2008) A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456:259-263
9. Canny G, Levy O, Furuta GT et al (2002) Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci USA 99:3902-3907
10. Canny G, Cario E, Lennartsson A et al (2006) Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein. Am J Physiol Gastrointest Liver Physiol 290:G557-G567
11. Cash HL, Whitham CV, Behrendt CL et al (2006) Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313:1126-1130
12. Cunliffe RN, Rose FRAJ, Keyte J et al (2001) Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some viloous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 48:176-185
13. Cuthbert AP, Fisher SA, Mirza MM et al (2002) The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122:867-874
14. Danese S (2012) New therapies for inflammatory bowel disease: from the bench to the bedside. Gut 61(6):918-32
15. de LE, Rajabi M, Zou G et al (2009) Selective arginines are important for the antibacterial activity and host cell interaction of human alpha-defensin 5. FEBS Lett 583:2507-2512
16. Dignass A, Preiss JC, Aust DE et al (2011) [Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011]. Z Gastroenterol 49:1276-1341
17. Doetze A, Satoguina J, Burchard G et al (2000) Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int Immunol 12:623-630
18. Elphick D, Liddell S, Mahida YR (2008) Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin. Am J Pathol 172:702-713
19. Fellermann K, Stange DE, Schaeffeler E et al (2006) A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79:439-448
20. Franke A, McGovern DP, Barrett JC et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 42:1118-1125
21. Gaffen SL (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9:556-567
22. Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710-720
23. Ghosh D, Porter EM, Wilk DJ, Poles MA, Ganz T, Bevins CL (2000) Proteolytic cleavage of human intestinal defensin 5 (HD5) precursor by intestinal proteases. Gastroenterology 118(4): A839, Ref Type: Abstract
24. Ghosh D, Porter E, Shen B et al (2002) Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 3:583-590
25. Guindi M, Riddell RH (2004) Indeterminate colitis. J Clin Pathol 57:1233-1244
26. Hampe J, Cuthbert A, Croucher PJ et al (2001) Association between insertion mutation in NOD2 gene and Crohn's di German and British populations. Lancet 357(9272):1925-1928
27. Hiemstra PS (2002) Novel roles of protease inhibitors in infection and inflammation. Biochem Soc Trans 30:116-120
28. Hollox EJ, Armour JA, Barber JC (2003) Extensive normal copy number variation of a beta- defensin antimicrobial-gene cluster. Am J Hum Genet 73:591-600
29. Hollox EJ, Barber JC, Brookes AJ et al (2008) Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1. Genome Res 18: 1686-1697
30. Hunter MM, Wang A, McKay DM (2007) Helminth infection enhances disease in a murine TH2 model of colitis. Gastroenterology 132:1320-1330
31. Iimura M, Gallo RL, Hase K et al (2005) Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol 174:4901-4907
32. Inoue N, Tamura K, Kinouchi Y et al (2002) Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 123:86-91
33. Islam D, Bandholtz L, Nilsson J et al (2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7:180-185
34. Jager S, Stange EF, Wehkamp J (2010) Antimicrobial peptides in gastrointestinal inflammation. IntJ Inflam 2010:910283
35. Johansson ME, Ambort D, Pelaseyed T et al (2011a) Composition and functional role of the mucus layers in the intestine. Cell Mol Life Sci 68:3635-3641
36. Johansson ME, Larsson JM, Hansson GC (2011b) The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci USA 108(Suppl 1):4659-4665
37. Kaser A, Lee AH, Franke A et al (2008) XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134:743-756
38. Khan KJ, Ullman TA, Ford AC et al (2011) Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 106:661-673
39. Kiehne K, Brunke G, Meyer D et al (2005) Oesophageal defensin expression during Candida infection and reflux disease. Scand J Gastroenterol 40:501-507
40. Kocsis AK, Lakatos PL, Somogyvari F et al (2008) Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease. Scand J Gastroenterol 43:299-307
41. Koslowski MJ, Kubler I, Chamaillard M et al (2009) Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS One 4:e4496
42. Koslowski MJ, Teltschik Z, Beisner J et al (2012) Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease. PLoS Genet 8:e1002523
43. Kotarsky K, Sitnik KM, Stenstad H et al (2010) A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the intestinal mucosa. Mucosal Immunol 3:40-48
44. Lala S, Ogura Y, Osborne C et al (2003) Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 125:47-57
45. Langhorst J, Junge A, Rueffer A et al (2009) Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am J Gastroenterol 104:404-410
46. Mastroianni JR, Ouellette AJ (2009) (alpha)-defensins in enteric innate immunity: functional paneth cell (alpha)-defensins in mouse colonic lumen. J Biol Chem 284(41):27848-56
47. Maurice MM, Nakamura H, Gringhuis S et al (1999) Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 42:2430-2439
48. Medveczky P, Szmola R, Sahin-Toth M (2009) Proteolytic activation of human pancreatitis- associated protein is required for peptidoglycan binding and bacterial aggregation. Biochem J 420:335-343
49. Meyer-Hoffert U, Homef MW, Henriques-Normark B et al (2008) Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 57:764-771
50. Mondel M, Schroeder BO, Zimmermann K et al (2008) Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol 2:166-172
51. Nevalainen TJ, Graham GG, Scott KF (2008) Antibacterial actions of secreted phospholipases A2. Review. Biochim Biophys Acta 1781:1-9
52. Niyonsaba F, Iwabuchi K, Matsuda H et al (2002) Epithelial cell-derived human beta-defensin- 2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int Immunol 14:421-426
53. Niyonsaba F, Ogawa H, Nagaoka I (2004) Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 111:273-281
54. Nuding S, Fellermann K, Wehkamp J et al (2007) Reduced mucosal antimicrobial activity in Crohn's disease of the colon. Gut 56:1240-1247
55. Papo N, Shai Y (2003) Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes? Peptides 24:1693-1703
56. Pazgier M, Prahl A, Hoover DM et al (2007) Studies of the biological properties of human beta- defensin 1. J Biol Chem 282:1819-1829
57. Petnicki-Ocwieja T, Hrncir T, Liu YJ et al (2009) Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci USA 106:15813-15818
58. Peyrin-Biroulet L, Chamaillard M (2007) NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. J Endotoxin Res 13:135-139
59. Peyrin-Biroulet L, Beisner J, Wang G et al (2010) Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci USA 107:8772-8777
60. Rohrl J, Yang D, Oppenheim JJ et al (2010) Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol 184:6688-6694
61. Rumio C, Besusso D, Palazzo M et al (2004) Degranulation of paneth cells via toll-like receptor 9. Am J Pathol 165:373-381
62. Sallenave JM (2002) Antimicrobial activity of antiproteinases. Biochem Soc Trans 30:111-115
63. Salzman NH, Hung K, Haribhai D et al (2010) Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 11:76-83
64. Sartor RB (2005) Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease? Gut 54:896-898
65. Sass V, Schneider T, Wilmes M et al (2010) Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect Immun 78:2793-2800
66. Satsangi J, Silverberg MS, Vermeire S et al (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749-753
67. Scarpa M, Grillo A, Scarpa M et al (2012) Innate immune environment in ileal pouch mucosa: alpha5 defensin up-regulation as predictor of chronic/relapsing pouchitis. J Gastrointest Surg 16:188-201
68. Schauber J, Rieger D, Weiler F et al (2006) Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 18:615-621
69. Schlee M, Harder J, Koten B et al (2008) Probiotic lactobacilli and VSL#3 induce enterocyte beta- defensin 2. Clin Exp Immunol 151:528-535
70. Schmid M, Fellermann K, Fritz P et al (2007) Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease. J Leukoc Biol 81(4):907-15. doi:10.1189/jlb.0906581
71. Schroeder BO, Wu Z, Nuding S et al (2011) Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 469:419-423
72. Simms LA, Doecke JD, Walsh MD et al (2008) Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 57:903-910
73. Simms LA, Doecke JD, Roberts RL et al (2010) KCNN4 gene variant is associated with ileal Crohn's disease in the Australian and New Zealand population. Am J Gastroenterol 105 (10):2209-17
74. Stange EF (2009) For bugs in bile: the times they are a-changin'. Gastroenterology 136:1164-1167
75. Steinmann J, Halldorsson S, Agerberth B et al (2009) Phenylbutyrate induces antimicrobial peptide expression. Antimicrob Agents Chemother 53:5127-5133
76. Subramani DB, Johansson ME, Dahlen G et al (2010) Lactobacillus and Bifidobacterium species do not secrete protease that cleaves the MUC2 mucin which organises the colon mucus. Benef Microbes 1:343-350
77. Summers RW, Elliott DE, Urban JF Jr et al (2005a) Trichuris suis therapy in Crohn's disease. Gut 54:87-90
78. Summers RW, Elliott DE, Urban JF Jr et al (2005b) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128:825-832
79. Thachil E, Hugot JP, Arbeille B et al (2012) Abnormal activation of autophagy-induced crinophagy in paneth cells from patients with Crohn's disease. Gastroenterology 142:1097-1099
80. Tollin M, Bergman P, Svenberg T et al (2003) Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 24:523-530
81. Vaishnava S, Behrendt CL, Ismail AS et al (2008) Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci USA 105:20858-20863
82. Vaishnava S, Yamamoto M, Severson KM et al (2011) The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334:255-258
83. van Es JH, Jay P, Gregorieff A et al (2005) Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol 7:381-386
84. Voss E, Wehkamp J, Wehkamp K et al (2006) NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 281:2005-2011
85. Wang TT, Dabbas B, Laperriere D et al (2010) Direct and indirect induction by 1,25- dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem 285:2227-2231
86. Weber G, Heilborn JD, Chamorro Jimenez CI et al (2005) Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 124:1080-1082
87. Wehkamp J, Stange EF (2010) Paneth's disease. J Crohns Colitis 4:523-531
88. Wehkamp J, Fellermann K, Herrlinger KR et al (2002) Human beta-defensin 2 but not beta- defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 14:745-752
89. Wehkamp J, Harder J, Weichenthal M et al (2003) Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 9:215-223
90. Wehkamp J, Harder J, Wehkamp K et al (2004) NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 72:5750-5758
91. Wehkamp J, Salzman NH, Porter E et al (2005) Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 102:18129-18134
92. Wehkamp J, Chu H, Shen B et al (2006) Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett 580:5344-5350
93. Wehkamp J, Wang G, Kubler I et al (2007) The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 179:3109-3118
94. Wilson CL, Ouellette AJ, Satchell DP et al (1999) Regulation of intestinal a-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286:113-117
95. Yang D, Chertov O, Bykovskaia SN et al (1999) ß-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525-528
96. Yang D, Chen Q, Hoover DM et al (2003) Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 74:448-455
97. Yazdanbakhsh M, Kremsner PG, van RR (2002) Allergy, parasites, and the hygiene hypothesis. Science 296:490-494
98. Zanetti M (2005) The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol 7:179-196
99. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389-395
100. Zhao C, Wang I, Lehrer RI (1996) Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 396:319-322
101. Zilbauer M, Dorrell N, Boughan PK et al (2005) Intestinal innate immunity to Campylobacter jejuni results in induction of bactericidal human beta-defensins 2 and 3. Infect Immun 73:7281-7289